Invesco Ltd. trimmed its stake in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 88.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 58,039 shares of the technology company’s stock after selling 458,621 shares during the period. Invesco Ltd. owned approximately 0.16% of Novanta worth $8,867,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Empowered Funds LLC bought a new position in shares of Novanta during the 4th quarter valued at $26,000. Huntington National Bank lifted its holdings in Novanta by 53.6% in the fourth quarter. Huntington National Bank now owns 430 shares of the technology company’s stock valued at $66,000 after acquiring an additional 150 shares during the period. SBI Securities Co. Ltd. purchased a new position in Novanta in the fourth quarter worth about $97,000. Venturi Wealth Management LLC grew its stake in shares of Novanta by 6,500.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the technology company’s stock valued at $111,000 after purchasing an additional 715 shares during the period. Finally, Sanctuary Advisors LLC purchased a new stake in shares of Novanta during the 3rd quarter valued at about $232,000. Institutional investors own 98.35% of the company’s stock.
Novanta Trading Up 2.2 %
NASDAQ:NOVT opened at $115.34 on Thursday. The firm has a market capitalization of $4.15 billion, a price-to-earnings ratio of 69.07 and a beta of 1.42. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.79 and a quick ratio of 1.81. The business has a fifty day moving average price of $129.37 and a 200-day moving average price of $150.60. Novanta Inc. has a one year low of $98.76 and a one year high of $187.12.
Wall Street Analysts Forecast Growth
Separately, Robert W. Baird cut their target price on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a research report on Monday, March 3rd.
View Our Latest Research Report on NOVT
Novanta Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Stories
- Five stocks we like better than Novanta
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Can IBM’s Q1 Earnings Spark a Breakout for the Stock?
- What is Forex and How Does it Work?
- S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- Best Aerospace Stocks Investing
- Fundamentally Sound, These 5 Stocks Sold Off Anyway
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.